Alpine Immune Sciences, Inc. to Post Q1 2024 Earnings of ($0.41) Per Share, Oppenheimer Forecasts (NASDAQ:ALPN)

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Rating) – Oppenheimer issued their Q1 2024 earnings per share estimates for shares of Alpine Immune Sciences in a research note issued to investors on Friday, March 24th. Oppenheimer analyst M. Breidenbach expects that the biotechnology company will post earnings of ($0.41) per share for the quarter. The […]

Related Keywords

United States ,American , ,Charles Schwab Investment Management Inc ,Nasdaq ,Morgan Stanley ,Alpine Immune Sciences Inc ,Alpine Immune Sciences ,Jpmorgan Chase Co ,Alpine Immune Sciences Stock Down ,News Ratings For Alpine Immune Sciences Daily ,Alpine Immune Sciences Company Profile ,Institutional Trading Of Alpine Immune Sciences ,American International Group Inc ,Get Rating ,Alpine Immune Science ,Immune Sciences Stock Down ,Immune Sciences ,Alpine Immune ,International Group ,Sigma Investments ,Schwab Investment Management ,Alpine Immune Sciences Daily ,Nasdaq Alpn ,Alpn ,Medical ,Earnings Estimates ,Oppenheimer Holdings Inc ,